The difference becomes some what less when the moral entity in question says to the dying in want of that necessity "I could charge you less for this and still survive myself, but I won't", and especially more so when they use government regulatory capture to make sure that no one else is allowed to either.
"Survive" and "innovate" aren't the same thing; if pharmaceutical corporations did what you suggest here they should, we'd just be hearing about how evil it is that they don't develop new drugs any more because of all those evil profiteering CEOs.
It's just my socialist Utopianism showing. I'm saying that I hope that there's an alternative path to innovation that isn't innovation by the rich for the rich only. It's probably working about as well as can be expected under the current parameters, but damn it has some ugly warts now and again.
I'm just an armchair historiographer, but it seems to me that more or less all innovation is "by the rich for the rich only" -- at first. Pharmaceutical research, in its modern form, is a very young field; give it fifty years to grow up and figure out what the hell it's doing, and things may well look a lot more equitable.
